Own stem cells infused to fight Parkinson's in elderly
NCT ID NCT04772378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program gave 10 people with Parkinson's disease, aged 76 to 95, multiple infusions of their own stored stem cells to check if it is safe. The treatment used 200 million cells given through an IV over 18 weeks, followed by 6 weeks of monitoring. The goal was safety, not a cure, and participants needed to have previously banked their stem cells with the sponsor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?